News

Published on 2 Mar 2024 on Insider Monkey via Yahoo Finance

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript


Article preview image

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript February 29, 2024

Amphastar Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Greetings, and welcome to the Amphastar Pharmaceuticals fourth quarter earnings call. [Operator Instructions] Please note that certain statements made during this call regarding matters that are not historical facts including, but not limited to, management's outlook or predictions for future performance are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Forward-Looking Statements in the press release issued today and the presentation on the company's website. Also, please refer to our SEC filings, which can be found on our website and the SEC's website for a discussion of numerous factors that may impact our future performance.

NASDAQ.AMPH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to...

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) is set to release its Q3 2024 earnings on Nov 6, 2024...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this pie...

Insider Monkey · via Yahoo Finance 13 Oct 2024

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals...

On June 10, 2024, Floyd Petersen, Director at Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), execut...

GuruFocus.com · via Yahoo Finance 28 May 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphas...

Insider Monkey via Yahoo Finance 9 May 2024

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be...

Amphastar Pharmaceuticals (NASDAQ:AMPH) has had a rough three months with its share price down 19...

Simply Wall St. via Yahoo Finance 3 May 2024

Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares

William Peters, the Chief Financial Officer, Executive Vice President, and Treasurer of Amphastar...

GuruFocus.com via Yahoo Finance 9 Mar 2024

Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), a company specializing in the development, manufactu...

GuruFocus.com via Yahoo Finance 6 Mar 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript February 29, 2024 ...

Insider Monkey via Yahoo Finance 2 Mar 2024

Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance

Net Revenues: $178.1 million for Q4 2023, a 32% increase year-over-year.GAAP Net Income: $36.2 mi...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Institutional investors in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) lost 3.4% last week but...

Key Insights Given the large stake in the stock by institutions, Amphastar Pharmaceuticals' stock...

Simply Wall St. via Yahoo Finance 31 Jan 2024